NICE has said EUSA Pharma’s Qarziba for the rare childhood cancer high-risk neuroblastoma should not get regular funding from the NHS – but could be given interim funding on the Cancer Drugs Fund ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results